Frequently Asked
Questions

You can subscribe to our newsletter here!

You can find information about our subsidy rounds on our Program Page.

You can find more information about which projects are supported, evaluation criteria and selection procedure here.

After you fill in the registration form, you will be contacted by one of our business developers for more information.

There is a document which describes the process of filing a complaint. You can find it here: Annex 7 To TC Agreement Complaints Handling Rules

To file a complaint through our website, please go here.

We handle all information shared with Biotech Booster with care and confidentiality. This means that information is used only for the purpose for which it was shared and are not disclosed to third parties without prior permission.

How we spend our funds

 

At Biotech Booster, we want to be transparent about how we spend our funds. We feel a strong responsibility to use our resources solely for making biotechnology work. To demonstrate this, we have divided our cost categories into eight separate sections, as shown in the table above.

As portrayed in the table, the largest portion of our funding is dedicated to Level 2 projects, followed by Level 1 projects, the five Thematic Clusters, and a reservation for Phase 2, respectively.

The remaining resources are allocated to the daily operations of Biotech Booster’s central office, the growth and continuity of the community through activities such as masterclasses and external events, and the collaboration with experts.

Still have questions left?

Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter